About T-Therapeutics
Unleashing the power of natural T cells to reshape the clinical landscape for cancer patients
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Undisclosed
Team Size
51-100
Tracked Since
Oct 23, 2026
Web & Domain Identity
Official Website
t-therapeutics.com
Domain Registered Date
Apr 26, 2022
Social & Network Presence
X / Twitter Profile
@companies
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $91,000,000 · Series-A
Backed by Business Growth Fund, Cambridge Enterprise Ventures
- Capital Raise
Raised $59,000,000 · Series-A
Backed by Cambridge Innovation Capital, Digitalis Ventures
- Milestone
Website domain registered
t-therapeutics.com
Investors & Backers
Business Growth Fund
Cambridge Enterprise Ventures
Cambridge Innovation Capital
Digitalis Ventures
F-Prime Capital
Sanofi Ventures
Sofinnova Partners
Tencent
University of Cambridge Enterprise
Funding History
Series-A equity
· Nov 13, 2025
Round backers: Business Growth Fund, Cambridge Enterprise Ventures, Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sanofi Ventures, Sofinnova Partners, Tencent
$91,000,000 thepharmaletter.com
Series-A equity
· Nov 15, 2023
Round backers: Cambridge Innovation Capital, Digitalis Ventures, F-Prime Capital, Sofinnova Partners, Sanofi Ventures, University of Cambridge Enterprise
$59,000,000 bioworld.com
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026